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Abstract: Herceptin, the monoclonal antibody, was successfully immobilized on gold 
nanoparticles (GNPs) to improve their precise interactions with breast cancer cells (SK-BR3). 
The mean size of the GNPs (29 nm), as determined by dynamic light scattering, enlarged to 
82 nm after herceptin immobilization. The in vitro cell culture experiment indicated that human 
skin cells (FB) proliferated well in the presence of herceptin-conjugated GNP (GNP–Her), while 
most of the breast cancer cells (SK-BR3) had died. To elucidate the mechanism of cell death, 
the interaction of breast cancer cells with GNP–Her was tracked by confocal laser scanning 
microscopy. Consequently, GNP–Her was found to be bound precisely to the membrane of the 
breast cancer cell, which became almost saturated after 6 hours incubation. This shows that the 
progression signal of SK-BR3 cells is retarded completely by the precise binding of antibody 
to the human epidermal growth factor receptor 2 receptor of the breast cancer cell membrane, 
causing cell death.
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Introduction
For more than a decade, nanometer-sized gold nanoparticles (GNPs) have attracted 
considerable attention not only because of their size- and shape-dependent optical and 
electronic properties but also due to their latent uses in thermal imaging, catalysis, 
scattering analysis, photoelectronic devices, biomedical diagnostics, and other related 
fields.1–3 GNPs offer important new possibilities in cancer diagnosis and therapy4 and 
can be used in the imaging5,6 of tumors in their primary and secondary locations, as 
delivery agents for antitumor drugs, and for nonaggressive amputation treatments. The 
conveyance of the NPs to the tumor is a multistage technique.7 Systemically controlled 
NPs with tumor-binding ligands can accumulate in the cancer cell due to the additional 
disordered vasculature relative to noncontaminated tissue.6,7
Cancer is challenging to treat, so active diagnosis approaches in the early phases 
of cancer are life threatening. In this respect, imaging has become an essential instru-
ment in cancer medical trials and therapeutic replication.8 Fluorescent bioimaging is 
also of extreme importance for visualizing the manifestation and movement of specific 
particles, cells, and biological processes that affect the performance of tumors and/or 
their reaction to therapeutic medications.9 Therefore, an extensive series of fluorescent 
modules has been explored in in vitro bioimaging studies, including the biomarking 
of cancer tissues,10 angiogenic vasculature, and sentry lymph nodes.11 In this respect, 
numerous nanomaterials such as quantum dots, noble metal NPs, upconverted NPs, 
and new fusion nanocomposites of reduced graphene oxide and GNPs have great 
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potential for highly sensitive optical imaging of cancer in 
both in vitro and in vivo experiments. From this viewpoint, 
GNPs are innovative biocompatible nanoprobes, offering 
surfaces and cores that possess physicochemical properties 
(eg, optical chirality,12,13 fluorescence,14 near-infrared pho-
toluminescence,15 and ferromagnetism16) that offer novel 
openings for clinical diagnostics. As such, these tools will 
certainly play a vital part in the initial analysis and responsive 
recognition of tumors.
The multifunctional behavior of NPs offers exclusive ben-
efits for the tumor-specific transfer of imaging and medicinal 
agents.17 Monoclonal antibodies with substantially assorted 
structures and properties are economical to produce and 
have great feasibility as a class of tracking moieties.18 One 
of the most broadly studied monoclonal antibodies used as 
a targeting moiety for the distribution of agents is herceptin. 
Herceptin is a water-soluble antibody that binds to the human 
epidermal growth factor receptor 2 (HER2) found on the 
membrane of SK-BR3 cells.
In this study, SK-BR3 cells were attacked with herceptin-
conjugated GNPs (GNP–Her) for tumor treatment and diag-
nosis. Mercaptosuccinic acid (MSA)–immobilized GNPs 
were prepared by citrate reduction, followed by the coupling 
reaction of GNP with acid-terminated MSA. Herceptin was 
then immobilized on the surface of GNP (GNP–Her) to enrich 
the anticancer effects of chemotherapeutic agents.19–22 The 
surface properties of GNP and GNP–Her were characterized 
by Fourier transform infrared (FT-IR) spectroscopy, ultravi-
olet–visible (UV–vis) spectrometry, dynamic light scattering 
(DLS), and transmission electron microscopy (TEM). To 
estimate the cell compatibility and cytotoxicity of the GNPs 
and GNP–Her conjugates, human breast cancer cells (SK-
BR3) were cultured in the presence of GNPs. The intracel-
lular uptake of GNP–Her into the cells was also observed by 
confocal laser scanning microscopy (CLSM) and inductively 
coupled plasma mass spectrometry (ICP–MS).23
Materials and methods
Auric chloride (HAuCl
4
), sodium citrate (Na
3
C
6
H
5
O
7
), MSA, 
and herceptin were purchased from Hoffman-La Roche Ltd 
(Basel, Switzerland). Cell culture reagents, fetal bovine 
serum, Dulbecco’s Modified Eagle’s Medium (DMEM), 
penicillin–streptomycin mix, trypsin–ethylene diamine 
tetraacetic acid (EDTA) solution, Dulbecco’s phosphate-
buffered saline (PBS), and cell viability staining reagents 
were provided by Gibco BRL (Thermo Fisher Scientific, 
Waltham, MA, USA), and the cells (SK-BR3 and FB) were 
purchased from the Korean Cell Line Bank.
synthesis of monodispersed gnPs
GNPs were prepared according to the method outlined by 
Anshup et al.24 Briefly, in a 250 mL round-bottomed flask, 
100 mL of 0.05% HAuCl
4
 was added and heated. Under 
prompt stirring, 3.5 mL of sodium citrate (1%) was supple-
mented and further rapidly stirred for 15 minutes at 120°C. 
After 30 minutes of stirring, the solution was then steadily 
cooled to room temperature. The citrate concentration was 
adjusted to attain different particle sizes. After 15 minutes, 
the liquid was removed and cooled to room temperature and 
filtered. The prepared GNPs were resuspended and purified by 
centrifugation and double precipitation from distilled water.
Preparation of hydrophilic gnPs
MSA (0.16 M) was dissolved in 70 mL of water in a 250 mL 
three-necked flask containing GNPs. The solution was stirred 
for 3 hours in nitrogen atmosphere. After the reaction was 
complete, the water was separated by vacuum, and the residue 
was transferred into a centrifuge tube and mixed with 4 mL 
of water. Subsequently, 20 mL of water was added to the 
mixed solution, and the precipitated product was separated 
and subjected to centrifugation at 3,000 rpm (revolutions per 
minute) for 15 minutes and washed with water. The prepared 
MSA-conjugated GNPs were dissolved and purified by cen-
trifugation and double precipitation from water.
immobilization of herceptin on gnPs
The immobilization of herceptin on GNPs (GNP–Her) was 
carried out by the reaction of water-soluble GNPs with hercep-
tin (Figure 1). Water-soluble GNPs (1.2 mmol) and herceptin 
HS–CH–COOH
S–CH–COOH
S–CH–COOH
GNP
WSC
WSC Herceptin
Herceptin
EDA
CH2–COOH
CH2–COOH
CH2–CONH–CH2–CH2–NH2
S–CH–COOH
CH2–CO–NH–CH2–CH2–NH–OC
GNP
GNP
AuCl3 Na3C6H5O7+ +
Figure 1 schematic diagram showing the immobilization of herceptin on mercapto-
succinic acid-coated gold nanoparticles.
Abbreviations: eDa, ethylenediamine; gnP, gold nanoparticle; WsC, water-
soluble carbodiimide.
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(7 mmol) were added to a two-necked flask and dissolved in 
10 mL of PBS buffer. 1-Ethyl-3-(3-dimethylaminopropyl)
carbodiimide (EDC; 2 mmol) and N-hydroxysuccinimide 
(NHS; 2 mmol) were supplemented to the reaction solution, 
followed by stirring for nearly 5 hours at room temperature. 
The reaction product was filtered to remove the precipitate 
and added to a 100,000 molecular weight cutoff dialysis 
membrane in deionized water for 24 hours to discard the 
unreacted EDC, herceptin, and NHS. Lastly, the solution 
was filtered through a 0.45 µm membrane and dried under 
vacuum for 24 hours.
Preparation of cyanine  
dye–gnP–her conjugates
Cyanine dye 5 (Cy5)-conjugated GNP–Her was obtained 
by reacting 1.5×10-3 mol/L GNP–Her with 4.8×10-5 mol/L 
fluorescent Cy5 in a carbonate buffer solution. The concen-
tration of Cy5 dye was examined by UV–vis spectroscopy to 
calculate the number of NPs internalized into the cytoplasm 
of SK-BR3.25
Results
Characterization of surface-modified 
gnPs
The immobilization of herceptin and Cy5 dye on surface-
modified GNPs was recorded by UV–vis absorption spectrum 
from aqueous solution at room temperature using a Hitachi 
U-3000 spectrophotometer. The core diameter and the sur-
face morphology of GNPs were observed by TEM (Philips 
CM-200, 120 kV). The samples for TEM observations were 
diluted with distilled water and deposited on Formvar-coated 
400-mesh copper grids. After drying the GNP–fluid thin 
film on the copper grid, a thin carbon film, approximately 
10–30 nm in thickness, was deposited on the NP film. The size 
and hydrodynamic diameter distribution of the GNPs were 
determined by DLS using a light-scattering spectrometer 
BI90 (Brookhaven, Long Island, NY, USA).
Cell culture
SK-BR3 (breast cancer cells) was used as the target cell, and 
FB (human skin cells) was used as the control cell line. In a 
humidified atmosphere containing 5% CO
2
, the cells were 
cultured routinely in a polystyrene dish at 37°C using 10 mL 
of McCoy medium or DMEM, supplemented with 10% fetal 
bovine serum and 1% penicillin–streptomycin G sodium. 
The medium was changed every 3 days. For subculture, 
the cells were washed twice with PBS and incubated with a 
trypsin–EDTA solution (0.25% trypsin, 1 mM EDTA) for 
10 minutes at 37°C to detach the cells. Complete media were 
then added to the polystyrene dish at room temperature to 
prevent the effects of trypsin. The cells were washed thrice by 
centrifugation method and resuspended in a new culture dish. 
To observe the morphology of cells, the cells were seeded in 
a 10 mL Petri dish at a concentration of 1×105 cells/mL and 
incubated for 3 days with GNP and GNP–Her. The surface 
morphology of adhered cells was observed by Nikon Eclipse 
TS100 optical microscopy.
Cell viability
To study the cytotoxic effects of GNP–Her, after 3 days of 
culture, the SK-BR3 and FB cells were suspended in PBS at 
a density of 1×105 cells/mL. Subsequently, the cell suspen-
sion was mixed with 100 µL of the assay solution (10 µL 
propidium iodide–calcein AM) and incubated for 15 minutes 
at 37°C. The cells were then observed by fluorescence micros-
copy (Axioplan 2; Carl Zeiss Meditec AG, Jena, Germany) 
for the simultaneous observation of live and dead cells.
intracellular uptake of gnPs
For the observation of effective cellular uptake of NPs via 
CLSM and fluorescence microscopy, the cells were seeded 
at a concentration of 1×105 cells/mL in a 10 mL culture dish 
and incubated for 24 hours. After 1 day, the medium was 
swapped with GNP and GNP–Her, containing a particle 
concentration of 50 µg/mL, and incubated for a certain 
period (2–7 hours) for the specific internalization of the 
NPs into the cells. The cells were then washed three times 
with PBS, and images were taken using a confocal laser 
microscope. A Carl Zeiss LSM 410 (Oberkochen, Germany) 
confocal laser scanning microscope was used to obtain the 
confocal images. The location and integrity of the internal-
ized GNP–Her conjugates were estimated by CLSM using 
4,6-diamidino-2-phenylindole dihydrochloride (DAPI, blue) 
as a marker, which stains the nuclei of the cells. The cell 
nuclei were stained by the addition of DAPI solution (10 µL) 
with proper mixing and incubated for 10 minutes. To track the 
GNP–Her NPs, GNP–Her and DAPI (488 nm) were added to 
the cells. The stained cells were washed at least three times 
with 1 mL of fresh DMEM and images were then taken by 
CLSM. To measure the intracellular uptake of the NPs, cells 
were grown in 24-well culture plates with roughly 105 cells in 
1 mL of the medium. After 20 hours’ incubation at 37°C, the 
cells were reseeded with culture medium containing GNP–
Her at a concentration of 2×10-4 cells/mL. The intracellular 
gold concentration was quantified using ICP–MS. Cells 
were washed with PBS, separated, resuspended, counted, 
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and centrifuged, and the cell pellets were dissolved in 37% 
HCl aqueous solution at 60°C–85°C for 40 minutes. The 
experiment was repeated three times, and the results were 
averaged with standard deviation.
statistical analysis
The cell multiplying experiment was conducted in triplicate 
and the results are presented as means ± standard deviations. 
The Student’s t-test was used to estimate the statistically 
significant difference between the results. Difference was 
considered statistically significant at P,0.05.
Discussion
surface characterization
The surface modification of GNP with herceptin was con-
firmed by UV–vis spectra, as shown in Figure 2. GNPs 
showed an absorption onset at 386 nm and after herceptin 
immobilization, they exhibited a red shift to 389 nm.26 This 
red shift was produced by strong quantum confinement due to 
the increase in particle size after metal-to-ligand charge trans-
fer.27,28 The surface modification of GNP with herceptin was 
also confirmed by FT-IR, as displayed in Figure 3. In the case 
of the GNP spectrum, the introduction of MSA on the surface 
of GNP was confirmed by the characteristic peak at 1,700 
cm-1 and 3,500 cm-1 (Figure 3A), which can be attributed to 
the free carboxyl (-COOH) and hydroxyl (-OH) groups.26,29 
Again, after reaction of GNP with herceptin, two new peaks at 
positions around 1,648 cm-1 and 1,540 cm-1 were observed in 
the spectrum of GNP–Her (Figure 3B), which are assigned to 
the amide I (-CO-NH-) and amide II (-CO-NH-) bonds, 
respectively.29 After the reaction of the free amine groups of 
GNP with herceptin, absorption at 1,648 cm-1 and 1,540 cm-1 
appeared, due to the amide groups of GNP–Her, proving the 
effective immobilization of herceptin over the GNPs.
Figure 4 represents the TEM images of GNP and GNP–
Her. The GNP has a spherical morphology, with a mean diam-
eter of ∼7.34 nm. In the case of GNP–Her, the particles had 
a mean diameter of ∼8.14 nm, were spherical in shape, and 
showed significantly monodispersed particles (Figure 4B). 
The larger particle size and nonaggregated particle mor-
phology was attributed to the conjugation of herceptin on 
the surface of the GNP. Figure 5 shows the typical sizes and 
size distributions of the synthesized GNPs and GNP–Her 
conjugates measured by DLS. The mean size of the GNPs, as 
determined by DLS, was ∼29 nm. On the other hand, the mean 
size of GNP–Her was almost ∼82 nm. The particle size, as 
determined by DLS, was significantly larger than that deter-
mined by TEM. This is because the DLS technique measures 
the mean hydrodynamic diameter of the GNP core bounded 
by the organic and solvation layers, and this hydrodynamic 
diameter is affected by the viscosity and concentration of 
the medium. TEM, however, gives the diameter of the core 
alone.27 The synthesis of Cy5 dye-immobilized GNP–Her 
was also confirmed by UV–vis absorption spectroscopy, 
as shown in Figure 6. The Cy5 dye-immobilized GNP–Her 
showed an absorption onset at 263 nm (Figure 6B) and after 
Cy5 dye immobilization, it exhibited a red shift to 680 nm 
(Figure 6A). This red shift was caused due to the increase in 
particle diameter.28
evaluation of cytotoxicity
Figure 7 shows the distinction of the “live/dead” dye-stained 
SK-BR3 and FB cells cultured in the presence of GNP and 
GNP–Her after 3 days of incubation. Using this qualitative 
method, the living and the dead cells were stained green and 
red, respectively, and were visible by fluorescence microscopy. 
Figure 7A shows that all the FB cells remained viable after 
3 days’ incubation, in the presence of NPs. On the other hand, 
after culturing for 3 days, in the presence of GNP–Her, most 
of the SK-BR3 cells had died, as shown in Figure 7B. Figure 8 
shows the viability of SK-BR3 cells cultured for 1 day and 
3 days in the presence of GNP–Her, as determined by the 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
 bromide)assay. After 1 day and 3 days of incubation, the 
level of SK-BR3 cell proliferation in the presence of GNP 
was similar to that of the cells cultured in the absence of NPs 
(polystyrene dish). On the other hand, cell propagation in the 
presence of GNP–Her was significantly lower than that in the 
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Figure 2 UV spectra of gnP and gnP–her.
Abbreviations: gnP, gold nanoparticle; gnP–her, herceptin-conjugated gnP; 
UV, ultraviolet.
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Figure 3 FT-ir spectra of gnP (A) and gnP–her (B) measured using the KBr method.
Abbreviations: FT-ir, Fourier transform infrared; gnP, gold nanoparticle; gnP–her, herceptin-conjugated gnP; KBr, potassium bromide.
Figure 4 TeM images of gnP (A) and gnP–her (B).
Abbreviations: TeM, transmission electron microscopy; gnP, gold nanoparticle; 
gnP–her, herceptin-conjugated gnP.
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Figure 5 Particle-size distributions of gnP (A) and gnP–her (B) measured 
by Dls.
Abbreviations: Dls, dynamic light scattering; gnP, gold nanoparticle; gnP–her, 
herceptin-conjugated gnP.
presence of GNP. Therefore, the GNP conjugated with her-
ceptin could increase the death of SK-BR3 cells considerably 
compared to the GNP without herceptin.
A probable explanation of this large decrease in cell viabil-
ity in the case of GNP–Her is that intracellularly distributed 
herceptin shows significant apoptotic activity by networking 
with several transcription factors related to cell propagation. 
Formerly, Bae et al30 stated that degradable heparin nanogels 
and heparin/chitosan polyelectrolyte nanocomplexes could 
effectively induce apoptosis via receptor-mediated  endocytosis 
through specific herceptin–HER2–integrin interaction. The 
endocytosed GNP–Her within the cells discharge free herceptin 
molecules in the cytoplasm by slicing the GNP– herceptin link-
age under the reductive intracellular  environment, which has a 
300 times greater glutathione concentration than  extracellular 
 medium.28 Glutathione is the main abundant reducing agent in 
the cytoplasm, helping in the dissipation of herceptin from the 
GNP by breaking the MSA–herceptin linkage. Furthermore, 
NPs are taken up by the cells through endocytosis, which 
disrupts the cell membrane, or weak cell adhesive interactions 
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with GNP may encourage apoptosis. GNPs conjugated with 
herceptin may act as cellular markers and target the receptors 
expressed on the cell exterior, with cellular internalization.31 
The receptors are highly controlled by the cell surface proteins, 
which facilitate the specific communication between cells and 
their extracellular environments, and they are usually confined 
on the plasma membrane.32
estimation of intracellular uptake
The quantity of GNP–Her taken up by SK-BR3 cells was 
estimated by ICP–MS and the outcomes are presented in 
 Figure 9. After herceptin conjugation, the NPs’ interaction 
with SK-BR cells was amplified significantly, in contrast 
to that of the original NPs, and increased to 1.4 pg per 
cell within the first day of culture, much higher than that 
of the original NPs.33 The peak internalization of GNP–
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Figure 6 UV–vis absorption spectra of the gnP–her-conjugated Cy5 dye (A), Cy5 
dye (B), and gnP (C) in aqueous solution.
Abbreviations: gnP, gold nanoparticle; gnP–her, herceptin-conjugated gnP; 
UV–vis, ultraviolet–visible.
Figure 7 Fluorescence microscopy.
Notes: Fluorescence microscopy images of live and dead FB (A) and sK-Br3 (B) 
cells after culturing for 3 days in a polystyrene culture dish in the presence of culture 
medium and gnP–her. The live and dead cells were stained and visualized in green 
and red, respectively, under a fluorescence microscope.
Abbreviations: gnP, gold nanoparticle; gnP–her, herceptin-conjugated gnP; 
FB, fibroblast cell line.
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Notes: absorbance as a measure of the cell proliferation of sK-Br3 cells cultured 
in the polystyrene culture dish (the blue bar), in the presence of gnP (the red bar), 
and with gnP–her (the green bar) for different time periods.
Abbreviations: gnP, gold nanoparticle; gnP–her, herceptin-conjugated gnP; 
MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
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cells at different incubation times, as determined by iCP–Ms.
Abbreviations: gnP, gold nanoparticle; gnP–her, herceptin-conjugated gnP; 
iCP–Ms, inductively coupled plasma mass spectrometry.
Her occurred at 4.6 pg per cell after 3 days of culture. The 
cause for the uptake enhancement might be ligand–receptor 
interactions on the cell  membrane.34  Moreover, the greater 
uptake of herceptin-modified GNPs indicates that the 
alteration not only enabled the NPs to target specific cells 
but also improved the cell internalization yield. Similar 
results obtained from ( carboxymethyl)chitosan- modified 
superparamagnetic iron oxide nanoparticles were shown by 
Shi et al35 in their reports; the quantity of NPs  internalized 
in human muscle-derived cells is much more than that of 
superparamagnetic iron oxide nanoparticles, as observed by 
ICP–MS. The interaction between herceptin and SK-BR3 
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A
50 µm 50 µm 50 µm
B C
Figure 10 Fluorescence images of sK-Br3 cells.
Notes: images were obtained from the culture of sK-Br3 cells for 1 hour (A), 3 hours (B), and 6 hours (C) in the presence of DAPI, and these show specific HER2 
interaction with herceptin.
Abbreviations: her2, human epidermal growth factor receptor 2; DaPi, 4,6-diamidino-2-phenylindole dihydrochloride.
receptors expressed on the membrane might have contributed 
to the enhancement of GNP–Her  internalization based on 
receptor-mediated endocytosis.36
The internalization of GNP–Her into SK-BR3 cells was 
also confirmed by CLSM. Figure 10 shows that herceptin is an 
effective antibody, binding specifically to the HER2-bearing 
breast tumor cells. The internalization of GNP–Her into 
SK-BR3 cells was confirmed by CLSM to characterize the 
delivery of GNP–Her to the cytoplasm of the SK-BR3 cells. 
The fluorescence image was derived from the nucleus of the 
SK-BR3 cells (DAPI, blue) and the internalized GNP–Her 
(red). The cells were cultured in the presence of GNP–Her at 
various incubation times. Weak GNP–Her conjugates were 
observed in the fluorescence image (red color) after 1 hour 
(Figure 10A) and slightly higher fluorescence was observed 
after 3 hours (Figure 10B). Intense fluorescence was noted 
after 6 hours (Figure 10C). On the other hand, the blue fluores-
cence derived from the nuclei stained with DAPI was strong 
after 1 hour of incubation, but it decreased with increasing 
incubation time and almost disappeared after 6 hours of 
incubation. In particular, the interaction of SK-BR3 with 
GNP–Her began after 1 hour of incubation and was acceler-
ated and saturated after 6 hours. The CLSM images suggest 
that the NP-mediated delivery of monoclonal antibodies was 
achieved efficiently, resulting in cell death.36 The mechanism 
of internalization involves endocytosis, followed by the release 
of herceptin-conjugated NPs to the cytoplasm.29,37 This sug-
gests that the growth signal of SK-BR3 cells is withdrawn 
completely by the specific binding of herceptin to the receptor 
on SK-BR3 membrane, resulting in cell death.35,36
Conclusion
MSA-coated GNP was conjugated successfully with hercep-
tin, which was confirmed by UV–vis and FT-IR spectroscopy 
techniques. The size of GNP determined by DLS was ∼79 nm, 
whereas that of the GNP–Her was ∼86 nm. GNP–Her had 
no cytotoxic effect on the control cells (FB) compared to the 
target cells (SK-BR3) and was internalized selectively into the 
target cells (SK-BR3); the free herceptin was delivered into the 
cytoplasm, which induced acute  apoptosis. The GNP–Her NPs 
underwent endocytosis in breast cancer cells (SK-BR3) largely 
through a receptor-facilitated mechanism, whereby herceptin 
conjugated on the NPs targets the HER2 expressed on the mem-
brane of the cancer cells.29 Therefore, GNP–Her has potential 
use in the optical imaging and treatment of breast cancer.
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